MultiplexDX is a biotechnology research firm that focuses on development of the technologies and products for molecular diagnostic markets.
MultiplexDX has raised $8.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
MultiplexDX's investors include EIC Accelerator, Crowdberry, LUMUS Investment Collective, Venture to Future Fund, IPA4SME.
MultiplexDX is headquartered in Gaithersburg, United States.
MultiplexDX is a biotechnology research firm that focuses on development of the technologies and products for molecular diagnostic markets.
MultiplexDX is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MultiplexDX — Funding & Investors." VCBacked, March 7, 2025, https://www.vcbacked.co/company/multiplexdx. Accessed August 14, 2026.
VCBacked. (2025). MultiplexDX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/multiplexdx
{{cite web |title=MultiplexDX — Funding & Investors |url=https://www.vcbacked.co/company/multiplexdx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated